Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.

Authors

• Ly Ngo
• Maromi Nei
• Jon Glass

Publication/Presentation Date

7-1-2006

Abstract

A 40-year-old man with a left frontotemporal grade II oligodendroglioma developed seizures that were refractory to 14 antiepileptic medications, the ketogenic diet, and epilepsy surgery. With temozolomide therapy, his seizure frequency gradually changed from 30 partial seizures per day to a single simple partial seizure in 6 months. No additional therapeutic measures were introduced during this time. This reduction in seizure frequency appears attributable solely to temozolomide therapy.

Volume

47

Issue

7

First Page

1237

Last Page

1238

ISSN

0013-9580

Published In/Presented At

Ngo, L., Nei, M., & Glass, J. (2006). Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma. Epilepsia, 47(7), 1237–1238. https://doi.org/10.1111/j.1528-1167.2006.00597.x

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

16886989

Department(s)

Administration and Leadership

Document Type

Article